BR0207817A - Processo para preparar um composto, e, composto - Google Patents
Processo para preparar um composto, e, compostoInfo
- Publication number
- BR0207817A BR0207817A BR0207817-1A BR0207817A BR0207817A BR 0207817 A BR0207817 A BR 0207817A BR 0207817 A BR0207817 A BR 0207817A BR 0207817 A BR0207817 A BR 0207817A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- synthesis
- chiral
- asymmetric
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- -1 and Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 238000011914 asymmetric synthesis Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000002902 organometallic compounds Chemical class 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0100764A SE0100764D0 (sv) | 2001-03-07 | 2001-03-07 | New assymetric process |
| PCT/SE2002/000376 WO2002070492A1 (en) | 2001-03-07 | 2002-03-05 | New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0207817A true BR0207817A (pt) | 2004-03-09 |
Family
ID=20283236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0207817-1A BR0207817A (pt) | 2001-03-07 | 2002-03-05 | Processo para preparar um composto, e, composto |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7045625B2 (https=) |
| EP (1) | EP1368325B1 (https=) |
| JP (1) | JP2004522793A (https=) |
| KR (1) | KR100856996B1 (https=) |
| CN (2) | CN1295217C (https=) |
| AT (1) | ATE406354T1 (https=) |
| BR (1) | BR0207817A (https=) |
| CA (1) | CA2440104A1 (https=) |
| DE (1) | DE60228548D1 (https=) |
| DK (1) | DK1368325T3 (https=) |
| ES (1) | ES2311050T3 (https=) |
| IL (1) | IL157460A0 (https=) |
| MX (1) | MXPA03007889A (https=) |
| NO (1) | NO325156B1 (https=) |
| NZ (1) | NZ527656A (https=) |
| PT (1) | PT1368325E (https=) |
| SE (1) | SE0100764D0 (https=) |
| SI (1) | SI1368325T1 (https=) |
| WO (1) | WO2002070492A1 (https=) |
| ZA (1) | ZA200306448B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114560781A (zh) * | 2022-03-01 | 2022-05-31 | 无锡捷化医药科技有限公司 | 一种n,n-二(2-氯乙基)-4-硝基苯基丙氨酸甲酯的制备方法 |
| CN114702457A (zh) * | 2022-03-30 | 2022-07-05 | 青岛科技大学 | 一种二芳基甲胺类化合物的绿色合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9202238D0 (en) * | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| CN1054850C (zh) * | 1993-07-30 | 2000-07-26 | 德尔塔药物公司 | 用于治疗的哌嗪化合物 |
| SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE9904673D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE0001209D0 (sv) | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
-
2001
- 2001-03-07 SE SE0100764A patent/SE0100764D0/xx unknown
-
2002
- 2002-03-05 BR BR0207817-1A patent/BR0207817A/pt not_active IP Right Cessation
- 2002-03-05 CA CA002440104A patent/CA2440104A1/en not_active Abandoned
- 2002-03-05 US US10/468,989 patent/US7045625B2/en not_active Expired - Fee Related
- 2002-03-05 WO PCT/SE2002/000376 patent/WO2002070492A1/en not_active Ceased
- 2002-03-05 ES ES02701852T patent/ES2311050T3/es not_active Expired - Lifetime
- 2002-03-05 NZ NZ527656A patent/NZ527656A/en unknown
- 2002-03-05 DE DE60228548T patent/DE60228548D1/de not_active Expired - Fee Related
- 2002-03-05 CN CNB2005100879382A patent/CN1295217C/zh not_active Expired - Fee Related
- 2002-03-05 SI SI200230739T patent/SI1368325T1/sl unknown
- 2002-03-05 IL IL15746002A patent/IL157460A0/xx unknown
- 2002-03-05 PT PT02701852T patent/PT1368325E/pt unknown
- 2002-03-05 KR KR1020037011675A patent/KR100856996B1/ko not_active Expired - Fee Related
- 2002-03-05 DK DK02701852T patent/DK1368325T3/da active
- 2002-03-05 AT AT02701852T patent/ATE406354T1/de not_active IP Right Cessation
- 2002-03-05 EP EP02701852A patent/EP1368325B1/en not_active Expired - Lifetime
- 2002-03-05 MX MXPA03007889A patent/MXPA03007889A/es active IP Right Grant
- 2002-03-05 CN CNB028060326A patent/CN1244565C/zh not_active Expired - Fee Related
- 2002-03-05 JP JP2002569812A patent/JP2004522793A/ja active Pending
-
2003
- 2003-08-19 ZA ZA200306448A patent/ZA200306448B/en unknown
- 2003-09-05 NO NO20033944A patent/NO325156B1/no not_active IP Right Cessation
-
2005
- 2005-11-22 US US11/285,672 patent/US7423154B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL157460A0 (en) | 2004-03-28 |
| EP1368325A1 (en) | 2003-12-10 |
| CN1721407A (zh) | 2006-01-18 |
| KR100856996B1 (ko) | 2008-09-04 |
| CA2440104A1 (en) | 2002-09-12 |
| SE0100764D0 (sv) | 2001-03-07 |
| NO20033944L (no) | 2003-10-31 |
| JP2004522793A (ja) | 2004-07-29 |
| WO2002070492A1 (en) | 2002-09-12 |
| ZA200306448B (en) | 2004-09-08 |
| NO325156B1 (no) | 2008-02-11 |
| CN1244565C (zh) | 2006-03-08 |
| ES2311050T3 (es) | 2009-02-01 |
| CN1295217C (zh) | 2007-01-17 |
| MXPA03007889A (es) | 2003-12-04 |
| US7045625B2 (en) | 2006-05-16 |
| EP1368325B1 (en) | 2008-08-27 |
| DK1368325T3 (da) | 2008-11-24 |
| KR20030080075A (ko) | 2003-10-10 |
| US20060074238A1 (en) | 2006-04-06 |
| US20040077861A1 (en) | 2004-04-22 |
| SI1368325T1 (sl) | 2008-12-31 |
| HK1059436A1 (en) | 2004-07-02 |
| NO20033944D0 (no) | 2003-09-05 |
| NZ527656A (en) | 2005-04-29 |
| ATE406354T1 (de) | 2008-09-15 |
| DE60228548D1 (de) | 2008-10-09 |
| PT1368325E (pt) | 2008-10-27 |
| US7423154B2 (en) | 2008-09-09 |
| CN1494532A (zh) | 2004-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0411268A (pt) | processo para a preparação de um composto 3-aril butil-amina substituìdo | |
| CR10177A (es) | Resolución de sal quiral. (divisional) | |
| NO20052912L (no) | Metode for fremstilling av krystallinske former for optiske enantiomerer av modafinil | |
| ATE486850T1 (de) | Synthese von enantiomerenreinen, aminosubstituierten kondensierten bicyclischen ringen | |
| BRPI0407282A (pt) | Processo para preparação de inibidores de pirrolotriazina cinase | |
| RU2002130710A (ru) | Производное пиридин-1-оксида и способ его преобразования в фармацевтически эффективные соединения | |
| BR0111472A (pt) | Processo para a preparação de um composto, composto, e, forma polimórfica de um composto | |
| DE60228724D1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| EA200701738A1 (ru) | Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина | |
| AR072336A1 (es) | Derivados de la 3-carboxipropil-aminotetralina, composiciones farmaceuticas que los contienen, procedimiento para su preparacion, intermediarios y su procedimiento de preparacion | |
| BR0207817A (pt) | Processo para preparar um composto, e, composto | |
| BRPI0500590B8 (pt) | processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável | |
| BRPI0408680A (pt) | processo para produzir álcoois e aminas enantiomericamente enriquecidos | |
| BRPI0407844A (pt) | processo para preparação de formas enancioméricas de derivados de 1,3-ciclohexanodiol com configuração cis | |
| PT1317455E (pt) | Processo para a preparacao de um composto de imidazopiridina substituido | |
| DE602004008486D1 (de) | Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol | |
| ATE280769T1 (de) | Verfahren zur herstellung von vitronectin- rezeptorantagonisten | |
| DE602004006021D1 (de) | Verfahren zur racematspaltung von nefopam | |
| ECSP034515A (es) | Proceso para producir compuestos quirales | |
| BR0116853A (pt) | Processo para a preparação de um composto, e, composto. | |
| ATE346837T1 (de) | Verfahren zur herstellung des inneren salzes von (r)- or (s)-aminocarnitin, salze und derivate davon | |
| UA91153C2 (ru) | Способ получения формы и венлафаксина гидрохлорида | |
| WO2004031153A3 (en) | Enantioselective alkylation of tricyclic compounds | |
| AR046627A1 (es) | Procesos para la preparacion de ftalimidas n- sustituidas | |
| BR0311761A (pt) | Processo para a preparação de 4,6-dicloro-5-fluorpirimidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |